DKNGDraftKings Inc.

🇺🇸 US
Smart Money 33
19.36
USD
Analysis Scores
Lothien Robustness Score?
-
Neden bu skor?
Damodaran ?
-
Dalio Risk ?
-
Piotroski ?
3/9
Weak
Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Graham ?
Negatif HBK
Company is loss-making (EPS = -0.3365 TL) — Graham formula requires positive earnings
Lothien Robustness Summary
3/100
Lothien Sağlamlık: Çok Zayıf (3/100)
Temel göstergelerin çoğu olumsuz. Lothien sağlamlık skoru düşük seviyede. | Kısa Vade: Olumlu | Uzun Vade: Olumsuz | Pozitif: 1 | Negatif: 8 | Nötr: 1
Net Zarar
Son çeyrekte -$469M zarar açıklandı. Yatırımcı dikkatli olmalı.
Çeyreklik Kâr Düşüşü
Net kâr bir önceki çeyreğe göre %-593.3 geriledi (-$68M → -$469M). Kısa vadede olumsuz sinyal.
Yıllık Kâr Geriledi
Geçen yılın aynı dönemine göre net kâr %-82.5 düştü. Uzun vadede endişe verici.
4 Çeyrek Üst Üste Düşüş
Son 4 çeyrek üst üste kâr düşüyor. Aşağı trend endişe verici. Sonraki çeyreğe dikkat.
Yüksek PD/DD
PD/DD: 51.68. Piyasa defter değerinin çok üstünde fiyatlıyor. Büyüme beklentisi primli.
Yüksek EV/EBITDA
EV/EBITDA: 84.7. Pahalı değerleme.
Negatif ROE
ROE: %-101.1. Şirket özsermayesini eritiyor.
Lothien Sağlamlık Skoru: 18/100
Bileşik algoritma değerlendirmesine göre şirketin finansal yapısı zayıf görünüyor.
Özkaynak Eriyor
Özkaynak çeyreklik %-68.5 düştü. Zarar veya temettü ile sermaye eriyor.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+62.3 artabilir (-$469M → -$177M).

Data date date not measured Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date date not measured
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Çok Yüksek
252 days
Annual Volatility ?
%55.5
VaR 95% ?
%5.87
daily max loss
VaR 99% ?
%8.25
daily max loss
CVaR 95% ?
%8.82
expected loss (tail)
Max Drawdown ?
%48.9
05.01.2026 → 06.11.2026
Skewness ?
-0.95
Parametrik%5.87
Historik%5.47
Cornish-Fisher%6.34
Return Distribution
Valuation
Potential?
-
Balance Sheet Analysis? Q2026/9
Net kâr çeyreklik %-593.3 düşerek -468.7M USD oldu
Yıllık net kâr %-82.5 geriledi
Hasılat çeyreklik %-7.9 düştü (1.3B USD)
Yıllık hasılat büyümesi güçlü (%+16.2)
Net kâr marjı negatif: %-35.3 — zarar ediyor
Cari oran < 1: 0.99x — likidite riski
Nakit %+11.9 arttı → 1.1B USD
İşletme nakit akışı pozitif: 25,000 USD
Serbest nakit akışı negatif: -43.7M USD — yatırımlar nakdi aşıyor
ROE negatif: %-260.9 — zarar var
ROA düşük: %-10.2
Toplam varlıklar %+7.8 büyüdü → 4.6B USD
Özkaynak %-68.5 azaldı → 179.6M USD
İşletme kârı negatif: -493.1M USD — faaliyet zararı
Net işletme sermayesi negatif: -24.2M USD — kısa vadeli baskı
İşletme sermayesi değişimi: %-192.0
CAPEX: 43.8M USD (Hasılatın %3.3'i)
Son 2 çeyrek ardışık zarar
Fiyat TRAMA-99 altında: %-29.0 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 27.27 USD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %-35.3
Net profit margin %-35.3 — loss period. Compared to previous quarter -30.6 point decrease.
ROE - Return on Equity (TTM) %-101.1
ROE %-101.1 — negative return on equity.
Free Cash Flow Margin (TTM) %3.2
TTM Free Cash Flow is %3.2'i. Moderate FCF — capex constraining operational profit.
Valuation
P/B Ratio 51.68x Sector: 4.55x
PD/DD 51.68x — sector median's %1036 above. Expensive book value.
EV/EBITDA 84.7x Sector: 15.6x
EV/EBITDA 84.7x — sector median's (15.6x) %442 above. Expensive relative to EBITDA.
Indebtedness
Current Ratio 0.99x
Current ratio 0.99x — short-term liabilities exceed current assets. Liquidity risk.
Net Debt / EBITDA 20.8x
Net Debt/EBITDA 20.8x — excessive leverage. Fragile debt profile.
Debt / Equity 12.71x
Debt/Equity 12.71x — very high leverage.
Interest Coverage 3.0x
Interest coverage 3.0x — interest obligations comfortably covered.
Growth
Revenue Growth (YoY) %+16.2
Revenue YoY %16.2 grew — healthy growth rate.
Net Profit Growth (YoY) %-82.5
Loss %82.5 increased — losses deepening.
Seasonality Analysis Q2 (Nis-Haz)
Historically strongest quarter: Q2 (Apr-Jun) (avg. profit 51.4M). Weakest quarter: Q3 (Jul-Sep) (avg. profit -339.7M).
Score Explanations
Lothien Robustness
-
Very weak robustness (18/100). Multiple critical indicators are red: high debt, low profitability or excessive valuation.
Potential
-
Minus %38.2 expected value (11.55) vs current price comparison. 2/4 valuation models could be calculated. Model confidence %51.
Components: P/B target: 4.68 | EV/EBITDA target: 4.68
Damodaran Valuation
-
Low Damodaran score (8/100). ROIC (%-28.9) below cost of capital. DCF analysis does not support current price.
Very Weak
Dalio Risk Analysis
-
High debt risk (28/100). Interest coverage ratio 3.0x — acceptable. Debt/EBITDA 20.8x — high debt burden.
Leverage: 0/100 | Debt Service: 56/100 | Quality: 12/100
ROIC - Return on Capital
%-28.9
ROIC (%-28.9) cost of capital (9.4%) below → destroying value.
WACC: %9.4
Debt Cycle Phase
Contraction
High debt service + falling revenues. Balance sheet under pressure.
Piotroski F-Score
3/9
Weak Piotroski (3/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Weak
Graham Intrinsic Value
—
Company is loss-making (EPS = -0.3365 TL) — Graham formula requires positive earnings
⚖️ Sector Comparison
P/B Ratio
51.68x vs 4.55x
Compared to sector %1036 more expensive (by book value)
EV/EBITDA
84.7x vs 15.6x
Compared to sector %442 higher EV/EBITDA
ROIC vs WACC
%-28.9 vs %9.4 WACC
ROIC 38.3 bps below cost of capital
Net Profit Margin (TTM)
%-5.9 vs %1.7 EBITDA margin
TTM net profit margin %-5.9
TRAMA-99 Trend — Strong Downtrend
Price (19.36), TRAMA-99 line's %29.0 below. Significant downtrend. TRAMA line acts as strong technical resistance.
Price:: 19.36
TRAMA: 27.27
Difference: %-29.0
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ içeriden alım · ▼ içeriden satım · ★ katalizör (haber-sezgisel) · ■ 13D aktivist · ■ 13G pasif — SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
Kurumsal Holdings — 13F (çeyreklik) ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

DKNG — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.